Google Translate is convenient, but healthcare organizations have to answer two separate questions before using it with patients: can the workflow handle PHI under HIPAA, and is the translation appropriate for clinical care? Consumer Google Translate should not be treated as a PHI workflow. Google Cloud Translation is a separate cloud service that Google currently lists among the products covered by its BAA.
Neither product is the same as a purpose-built AI medical interpreter. An AI medical interpreter is designed for live patient-clinician communication and can add healthcare-specific capabilities such as real-time speech-to-speech interpretation, medical terminology handling, quality checks, EHR connections, telehealth, and human escalation.
For healthcare teams, the better comparison is product scope, PHI flow, clinical quality, and workflow fit. A covered translation API can still sit inside a poorly designed PHI workflow, and a secure translation can still be medically wrong.
TLDR:
- Do not use the consumer Google Translate site or app as the clinical path for identifiable patient information.
- Google Cloud Translation is a separate service and appears on Google's current BAA-covered product list.
- Cloud Translation says customer text is used only to provide the service, is held briefly in memory for translation, and is not used to improve its translation models.
- Audit logging is available for Cloud Translation Advanced v3, but Google says it is not available for Basic v2. That difference matters for healthcare audit trails.
- The highest-value review is the full PHI path: source text, translated output, storage, logs, connected apps, EHR import, and any human review step.
Is Google Translate HIPAA compliant? Start with the exact product
Google uses similar branding for two very different workflows.
The consumer Google Translate website and mobile app are general-purpose services for individual users. Google Cloud Translation is a cloud API used inside software and enterprise workflows.
Google's current HIPAA page lists Cloud Translation among the Google Cloud services covered by its BAA. Google also says HIPAA customers are responsible for accepting the BAA and building their own compliant solution with covered services.
That means the useful compliance question is not “Does Google have a BAA?” It is “Which exact Google service receives the PHI, and is that exact service inside our BAA-backed cloud workflow?”
Google Translate vs. AI medical interpretation: a healthcare comparison
The HIPAA question is only one part of the decision. Google Translate, Google Cloud Translation, and a purpose-built AI medical interpreter solve different problems.
| Evaluation area | Consumer Google Translate | Google Cloud Translation | AI medical interpreter |
|---|---|---|---|
| HIPAA / BAA | Do not treat as a PHI workflow | Cloud Translation is listed among Google Cloud BAA-covered services | Should support a healthcare BAA and healthcare security review |
| Designed for clinical interpretation | No | No, general-purpose translation API | Yes, when built for healthcare |
| Real-time speech-to-speech | Limited consumer voice translation | Not the core Cloud Translation workflow | Core capability for live patient-clinician communication |
| Medical terminology | General-purpose | Can use glossaries and custom terminology | Should be tested on medical terms, medications, and clinical speech |
| Clinical validation | Not designed around clinical validation | Customer must validate the healthcare use case | Look for healthcare-specific validation and error severity testing |
| Error monitoring | No healthcare-specific live quality layer | Customer builds review and monitoring logic | Can include turn-level checks for omissions, negation, numbers, and medical terms |
| Dialect support | Varies by consumer feature | Varies by supported language and model | Should be tested against the dialects used by the patient population |
| EHR integration | No | Customer builds it | Can connect directly with clinical workflows and documentation |
| Telehealth | Not designed as a clinical telehealth workflow | Customer builds the connection | Can support interpreted telehealth encounters |
| Encounter documentation | No clinical documentation workflow | Customer builds it | May connect interpretation with multilingual clinical documentation |
| Section 1557 workflow support | Not built for healthcare compliance workflows | Depends on how the organization builds and uses it | Should support the organization's language-access policy, review rules, and human escalation |
Healthcare organizations comparing these options should look at clinical validation, medical accuracy, language coverage, security, workflow integration, and human escalation. See our comparison of the best AI medical interpreters for healthcare.
For the technical side of live interpretation, see AI Medical Interpreter: How Real-Time Interpretation Works in Healthcare.
A better way to review Google translation for healthcare
| Layer | Question to ask | Why it matters |
|---|---|---|
| Product | Which Google service is handling PHI? | Consumer Google Translate and Google Cloud Translation are different services |
| Contract | Is that service covered by the organization's Google Cloud BAA? | BAA scope follows the exact covered service |
| Architecture | Where do source text, translated text, files, and logs go next? | A covered translation call can feed an uncovered downstream service |
| Auditability | Can the organization review who used the service and when? | Cloud Translation audit logging differs by API edition |
| Clinical quality | Does the translated document preserve medical meaning? | HIPAA does not measure translation quality |
This five-layer review is more useful than a vendor checkbox because it catches failures outside the translation call itself.
1. Product scope: consumer Translate and Cloud Translation are not interchangeable
A clinician pasting chart text into translate.google.com is not using the same workflow as an application sending content to Cloud Translation inside a managed Google Cloud project.
That distinction changes the contract, access controls, logging, and data path.
For a health system, policy language should name the approved product. “Google translation is approved” is too vague. “Cloud Translation within the approved Google Cloud project under our BAA” is much harder to misread.
2. Data use: Cloud Translation gives a more specific answer than many teams realize
Google's Cloud Translation data usage FAQ says customer content sent to the Cloud Translation API is used only to provide the service. Google also says the submitted text is held briefly in memory to perform the translation and return the result.
Google's API overview also states that customer data and translations are not used to improve Cloud Translation API models.
Those details are more useful than a generic security claim because they answer two concrete questions healthcare teams often ask during review: whether submitted clinical text is retained as training data and whether the translation service itself keeps the source text long term.
The next question is where your own application stores the source and translated output. That storage layer may become the longer-lived PHI record even when the translation API keeps text only briefly.
3. The hidden risk is often downstream of the translation API
Imagine a clinic builds a simple internal tool on top of Cloud Translation.
The translation request itself goes through a BAA-covered service. The translated file is then saved to cloud storage, copied into a support ticket, emailed to staff, or written into an analytics table.
Each downstream step becomes part of the PHI workflow.
HHS cloud guidance says organizations using cloud services for ePHI need to understand the cloud environment so they can perform their own risk analysis and set the right controls. Read the HHS guidance.
So the security review should follow the data after translation, not stop at the API endpoint.
A useful diagram contains:
- where the source text comes from
- which service receives it
- where the translated output goes
- whether a file is created
- where that file is stored
- who can retrieve it
- whether it moves into the EHR
- whether a human reviewer receives a copy
- what logs remain afterward
4. Auditability depends on which Cloud Translation API you use
Google's current audit-logging documentation says Cloud Translation Advanced v3 supports audit logging, while Basic v2 does not.
That is an important architecture choice for healthcare.
A security team may want to know which account called the service, when it happened, and what administrative changes occurred. If audit trails are part of the organization's security plan, the API edition can change what evidence is available.
This is also why a proof of concept built quickly with one API setup should not automatically become the production workflow.
Google's HIPAA guidance also warns customers against placing PHI in resource metadata because metadata can appear in logs. That is a subtle but useful reminder: PHI can leak into system fields even when the translated text itself is handled correctly.
5. A BAA-backed workflow can still be clinically unsafe
HIPAA answers questions about PHI privacy and security. It does not tell you whether a translated discharge instruction preserves the right medication dose.
A 2025 study of machine-translated emergency department discharge instructions found that at least one inaccuracy appeared in 16% of Spanish instruction sets, 24% of Chinese instruction sets, and 56% of Russian instruction sets, even though sentence-level results looked much stronger. Read the study.
That finding changes how healthcare teams should test translation.
Do not score only individual sentences. Score the complete document and ask whether any error changes what the patient should do.
A 12-page document with one wrong medication instruction is not a safe document because the other pages are correct.
The BAA question and the translation-review question should be separate
For a medical translation workflow, use two review tracks.
Security review asks:
- Is every service touching PHI inside the approved workflow?
- Are access and audit controls appropriate?
- Where are source and translated files stored?
- What happens when staff export or share the file?
Clinical review asks:
- Did any medication, dose, number, date, or warning change?
- Was any text omitted?
- Did formatting alter the order of instructions?
- Is the target-language text understandable to the patient population?
- Does the document type require qualified human review?
Section 1557 creates another reason to classify documents by risk
HHS guidance on Section 1557 says certain text-based machine translations require review by a qualified human translator when accuracy is required, the source contains complex or technical language, or the text affects rights, benefits, or meaningful access. Read the HHS language-access guidance.
That makes document classification useful.
A parking instruction, a medication change, and a consent document should not automatically follow the same review path.
Health systems can group common document types by clinical and legal risk, then set the review rule before staff start translating them.
What about de-identified text?
If information has been properly de-identified under HIPAA, it is no longer PHI. That changes the HIPAA analysis.
But de-identification is not the same as deleting a patient's name from a paragraph.
A clinical note can still identify a person through other details or combinations of facts. Teams that want to send de-identified text to a consumer tool need a real de-identification method, not an informal copy-and-delete habit.
For everyday clinical work, one approved translation route is often easier for staff than asking them to make a privacy judgment every time they need a sentence translated.
The shadow-workflow problem is bigger than one Google Translate request
The real risk of consumer translation tools is not one isolated sentence. It is the workflow that forms when staff repeatedly reach for the fastest public tool.
Once that habit exists, one person may paste a symptom list, another may paste a discharge note, and another may upload an entire document.
A good policy gives staff a fast approved alternative. Blocking a public tool without giving staff something equally easy usually leaves the underlying need unsolved.
That is one reason translation access should be designed like any other clinical workflow: approved tool, clear PHI rules, fast access, and a known review path.
Where a healthcare-specific service differs
Google Cloud Translation gives engineering teams a flexible translation API. The healthcare organization still builds the clinical workflow around it.
A healthcare-specific service can package more of that workflow together: medical document translation, real-time medical interpretation, multilingual documentation, PHI safeguards, and clinical review paths.
Opalite supports medical document translation alongside real-time AI medical interpretation across 150+ languages and dialects.
The useful comparison is not simply API accuracy. It is how much clinical and security workflow the organization has to build, govern, and maintain around the translation engine.
For a broader comparison, see Best AI Medical Translation Services for Healthcare.
A practical decision framework
- Use the consumer Google Translate site or app for PHI? No.
- Use Cloud Translation inside an approved Google Cloud workflow? Potentially, if the BAA, covered services, access controls, logs, storage, and connected systems have been reviewed.
- Assume a BAA proves medical accuracy? No.
- Assume removing the patient name makes text de-identified? No.
- Use the same review rule for every translated document? No. Match review to document risk.